Clinical Trial Update: Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety and efficacy of tegaserod for opioid-induced constipation in patients with non-cancer pain has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• Zelnorm (tegaserod)

Snippet

Sponsor: Novartis | Conditions: Opioid-induced Constipation | Phase 3 | Status: TERMINATED